SeaStar Medical Holding Corp
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Revenue | $1.2M | $135.0K | $0 |
| Cost of Revenue | $53.0K | $0 | $0 |
| Gross Profit | $1.2M | $135.0K | $0 |
| Gross Margin | 95.7% | 100.0% | — |
| Operating Expenses | |||
| Research & Development | $7.5M | $9.1M | $6.0M |
| SG&A Expense | $5.8M | $8.9M | $8.2M |
| Operating Income | $-12.2M | $-17.8M | $-14.2M |
| Operating Margin | -986.6% | -13,216.3% | — |
| Interest Expense | — | $244.0K | $1.1M |
| Pretax Income | $-12.1M | $-24.8M | $-26.2M |
| Income Tax Expense | $3.0K | $3.0K | $0 |
| Net Income | $-12.2M | $-24.8M | $-26.2M |
| Net Margin | -984.6% | -18,392.6% | — |
| EPS (Basic) | $-5.86 | $-66.33 | $-7.57 |
| EPS (Diluted) | — | $-6.63 | $-7.57 |
| Shares Outstanding (Basic) | 2.1M | 374.4K | 3.5M |
| Shares Outstanding (Diluted) | 2.1M | 3.7M | 3.5M |
| Dividends Per Share | — | — | — |